IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 108 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,061 | -9.5% | 2,522,244 | 0.0% | 0.90% | +25.2% |
| Q2 2023 | $23,280 | -32.5% | 2,522,244 | +0.5% | 0.72% | -64.8% |
| Q1 2023 | $34,487 | -18.9% | 2,509,972 | +0.4% | 2.05% | -13.7% |
| Q4 2022 | $42,526 | -99.9% | 2,500,000 | 0.0% | 2.37% | -2.2% |
| Q3 2022 | $56,850,000 | +53.8% | 2,500,000 | +22.0% | 2.43% | +22.9% |
| Q2 2022 | $36,962,000 | -30.9% | 2,050,000 | +2.5% | 1.97% | -11.8% |
| Q1 2022 | $53,460,000 | +21.5% | 2,000,000 | +33.3% | 2.24% | +87.4% |
| Q4 2021 | $43,995,000 | -50.4% | 1,500,000 | +11.1% | 1.19% | -39.9% |
| Q3 2021 | $88,776,000 | -3.0% | 1,350,000 | +22.7% | 1.99% | +6.9% |
| Q2 2021 | $91,520,000 | +6.1% | 1,100,000 | -2.2% | 1.86% | +21.9% |
| Q1 2021 | $86,276,000 | -18.6% | 1,125,000 | -6.2% | 1.52% | -33.0% |
| Q4 2020 | $105,948,000 | +108.4% | 1,200,000 | +74.2% | 2.27% | +84.3% |
| Q3 2020 | $50,848,000 | +788.3% | 688,910 | +359.3% | 1.23% | +458.4% |
| Q4 2019 | $5,724,000 | +61.2% | 150,000 | -25.0% | 0.22% | +55.6% |
| Q3 2019 | $3,550,000 | – | 200,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,425,455 | $225,258,000 | 3.93% |
| Artal Group S.A. | 1,350,000 | $88,776,000 | 1.99% |
| Eagle Bay Advisors LLC | 35,295 | $2,321,000 | 1.30% |
| Cormorant Asset Management, LP | 350,000 | $23,016,000 | 0.94% |
| Baker Brothers Advisors | 3,156,102 | $207,545,000 | 0.91% |
| Bruce & Co., Inc. | 55,000 | $3,616,000 | 0.77% |
| Altium Capital Management LP | 42,473 | $2,793,000 | 0.73% |
| HighVista Strategies LLC | 15,446 | $1,016,000 | 0.67% |
| Woodline Partners LP | 569,009 | $37,418,000 | 0.61% |
| Ikarian Capital, LLC | 100,000 | $6,576,000 | 0.46% |